We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Roche Passes EMA Probe Into Safety Reporting Deficiencies
Roche Passes EMA Probe Into Safety Reporting Deficiencies
The European Medicines Agency has concluded a review of lax adverse event reporting at Roche, concluding the company’s failure last year to report adverse events for 19 drugs did not cause any additional risks to consumers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor